Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
33 current organizations shown on this profile
Board positions
33 supported by public sources, 0 supplied by the profile owner
Committee roles
5Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Chief Executive Officer of ElevateBio LLC since December 2017. Previously served as CEO of AlloVir, Inc. and held multiple executive roles at Alexion Pharmaceuticals including CEO, COO, and Chief Commercial Officer. Extensive business experience and knowledge of company operations in life sciences.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Seer, Inc.

2018-01-01 · current

Confirmed by public sourceView source

Director

Kalaris Therapeutics, Inc.

2018-01-01 · current

Confirmed by public sourceView source

Director

Scholar Rock Holding Corp

2017-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Kalaris Therapeutics, Inc.

Open Kalaris Therapeutics, Inc. profile →

Director at Kalaris Therapeutics, Inc.

2018-01-01 → End not stated

current · source reported

Observed: 2026-09-25

Kalaris Therapeuti…Kalaris Therapeutics, Inc.Scholar Rock Holdi…Scholar Rock Holding CorpSeer, Inc.Seer, Inc.David Hallal

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingKalaris Therapeutics, Inc. director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 2 · Sec FilingSRRK DEF 14A executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open sourceSource 3 · Sec FilingSEER DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:david-hallal
Record version
public-0

Published evidence records

13 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Kalaris Therapeutics, Inc. director board source

    sec filing · Source published: Apr 24, 2026 · Retrieved: May 3, 2026

    Supports 5 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Kalaris Therapeutics, Inc. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Seer, Inc. · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 11, 2026

  2. KLRS DEF 14A director slate

    sec filing · Source published: Apr 24, 2026 · Retrieved: May 1, 2026

    Supports 2 claims
    • Board role: Board role: Chair · Claim reviewed: May 11, 2026
    • Committee assignments: Committee assignments: Compensation, Nominating/Governance · Claim reviewed: May 1, 2026

  3. Open source

    sec proxy · Source published: Apr 24, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Kalaris Therapeutics, Inc. · Claim reviewed: May 16, 2026

  4. SRRK DEF 14A executive officers

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 11, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Scholar Rock Holding · Claim reviewed: May 11, 2026
    • Executive title: Executive title: Principal Executive Officer · Claim reviewed: May 11, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  5. Scholar Rock Holding director board source

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 3, 2026

    Supports 4 claims
    • Board independence: Not independent (executive director) · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Kalaris Therapeutics, Inc. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Seer, Inc. · Claim reviewed: May 3, 2026

  6. SRRK DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 11, 2026

    Supports 2 claims
    • Board role: Board role: Chair · Claim reviewed: May 11, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 11, 2026

  7. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 29, 2026

    Supports 1 claim
    • Professional Role: Director at Scholar Rock Holding Corp · Claim reviewed: May 16, 2026

  8. SEER DEF 14A director slate

    sec filing · Source published: May 28, 2025 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Talent and Compensation, Corporate Governance and Nominating · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at ElevateBio LLC · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Executive Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  9. Open source

    sec proxy · Source published: May 28, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Seer, Inc. · Claim reviewed: May 16, 2026

  10. SRRK executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
    • Executive company: Executive at Scholar Rock Holding · Claim reviewed: May 11, 2026
    • Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Executive Officer · Claim reviewed: May 3, 2026

  11. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Seer, Inc. · Claim reviewed: May 3, 2026

  12. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Kalaris Therapeutics, Inc. · Claim reviewed: May 3, 2026

  13. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

AI expertise · Source reportedAI expertise: not identified in the cited filing1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

AI governance relevance · Source reportedAI governance relevance: not identified in the cited filing1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Under reviewNot independent (executive director)1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Under reviewIndependent director1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Kalaris Therapeutics, Inc.Supported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Scholar Rock HoldingSupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Seer, Inc.Supported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · CorroboratedBoard role: ChairSupported by 2 public records2 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 11, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

Board role · Source reportedBoard role: Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · CorroboratedNo committee assignment disclosed in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 11, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Audit, Talent and Compensation, Corporate Governance and Nominating1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · Source reportedCommittee assignments: Compensation, Nominating/Governance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at ElevateBio LLC1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · CorroboratedExecutive at Scholar Rock HoldingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 11, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive function · Source reportedOther Executive (OTHER_EXECUTIVE)1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: Chief Executive Officer1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Executive Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: Principal Executive Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 11, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources13 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

    Supports: Board role · Committee assignments

  3. https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at Kalaris Therapeutics, Inc. (NASDAQ: KLRS)

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Director since · Board independence

  6. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 11, 2026

    Supports: Board role · Committee assignments

  7. https://www.sec.gov/Archives/edgar/data/1727196/000110465926046917/tm261440-1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 29, 2026

    Supports: Director at Scholar Rock Holding Corp (NASDAQ: SRRK)

  8. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  9. https://www.sec.gov/Archives/edgar/data/1726445/000095017025078352/ck0001726445-20250528.htm

    Sec Proxy · Tier not stated · Reviewed Apr 28, 2026

    Supports: Director at Seer, Inc. (NASDAQ: SEER)

  10. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: AI expertise · AI governance relevance · Executive company · Executive function · Executive title

  11. https://www.sec.gov/Archives/edgar/data/1726445/000095017025078352/ck0001726445-20250528.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  12. https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  13. https://www.sec.gov/Archives/edgar/data/1727196/000110465926046917/tm261440-1_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership